OTCPK:MDXH.F

Stock Analysis Report

Executive Summary

MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in North America, Europe, and Asia.

Snowflake

Fundamentals

Worrying balance sheet with weak fundamentals.

Risks

  • MedX Health is not covered by any analysts.

Share Price & News

How has MedX Health's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

MDXH.F

0.7%

US Medical Equipment

-0.2%

US Market


1 Year Return

-32.4%

MDXH.F

9.5%

US Medical Equipment

1.1%

US Market

MDXH.F underperformed the Medical Equipment industry which returned 9.5% over the past year.

MDXH.F underperformed the Market in United States of America which returned 1.1% over the past year.


Share holder returns

MDXH.FIndustryMarket
7 Day0%0.7%-0.2%
30 Day11.7%0.1%2.5%
90 Day-20.0%2.5%1.6%
1 Year-32.4%-32.4%10.4%9.5%3.4%1.1%
3 Year-33.2%-33.2%69.3%64.1%45.2%35.8%
5 Year32.9%32.9%138.0%110.9%62.6%44.8%

Price Volatility Vs. Market

How volatile is MedX Health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is MedX Health undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether MedX Health is trading at an attractive price based on the cash flow it is expected to produce in the future. But as MedX Health has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of MDXH.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through MedX Health regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is MedX Health expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MedX Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of MDXH.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access MedX Health's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has MedX Health performed over the past 5 years?

-43.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

MedX Health does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare MedX Health's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare MedX Health's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if MedX Health has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

It is difficult to establish if MedX Health has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if MedX Health improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.


Next Steps

Financial Health

How is MedX Health's financial position?


Financial Position Analysis

MedX Health's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

MedX Health's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

MedX Health has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if MedX Health's debt level has increased considering it has negative shareholder equity.


Balance Sheet

High level of physical assets or inventory.

MedX Health has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

MedX Health has less than a year of cash runway based on current free cash flow.

MedX Health has less than a year of cash runway if free cash flow continues to grow at historical rates of 22.8% each year.


Next Steps

Dividend

What is MedX Health's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate MedX Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate MedX Health's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as MedX Health has not reported any payouts.

Unable to verify if MedX Health's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as MedX Health has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of MedX Health's salary, the management and board of directors tenure and is there insider trading?

4.6yrs

Average management tenure


CEO

Scott Spearn 0

1yrs

Tenure

0

Mr. Scott Spearn is President of MedX Health Corp since April 3, 2018 and serves as its Chief Executive Officer since September 18, 2018 and Director since September 18, 2018. Mr. Spearn has successfully b ...


Management Age and Tenure

4.6yrs

Average Tenure

The tenure for the MedX Health management team is about average.


Board Age and Tenure

2.7yrs

Average Tenure

73.5yo

Average Age

The average tenure for the MedX Health board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

SellCA$10,41112 May 19
Sinalta Investments Ltd
EntityCompany
Shares100,000
Max PriceCA$0.10

Ownership Breakdown


Management Team

  • Christopher Freeman

    Secretary

    • Tenure: 0yrs
  • Pete Holmes (51yo)

    Vice President of Sales

    • Tenure: 12.3yrs
    • Compensation: CA$63.29k
  • Louie Canitano

    Chief Operating Officer

    • Tenure: 5.7yrs
    • Compensation: CA$188.13k
  • Daniel Kaute

    Managing Director of Europe

    • Tenure: 3.6yrs
  • Jim Cooke

    Chief Financial Officer

    • Tenure: 5.8yrs
    • Compensation: CA$114.00k
  • Scott Naughton

    Managing Director of US Operations and Member of Advisory Board

    • Tenure: 2.8yrs
  • Scott Spearn

    President

    • Tenure: 1yrs

Board Members

  • David Hennigar (79yo)

    Independent Director

    • Tenure: 17.8yrs
  • N. Van Nest (83yo)

    Director

    • Tenure: 17.8yrs
  • Ken McKay (68yo)

    Independent Director

    • Tenure: 17.8yrs
  • Paul Cohen

    Member of Medical/Scientific Advisory Board

    • Tenure: 2.3yrs
  • Rob von der Porten

    Chairman of the Board

    • Tenure: 1yrs
    • Compensation: CA$85.00k
  • Daniel Siegel (61yo)

    Member of Medical Advisory Board

    • Tenure: 1.3yrs
  • David Breukelman

    Director

    • Tenure: 3.8yrs
  • Scott Naughton

    Managing Director of US Operations and Member of Advisory Board

    • Tenure: 2.8yrs
  • Dennis Reich

    Member of Medical/Scientific Advisory Board

    • Tenure: 2.6yrs
  • Scott Spearn

    President

    • Tenure: 1yrs

Company Information

MedX Health Corp's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: MedX Health Corp
  • Ticker: MDXH.F
  • Exchange: OTCPK
  • Founded: 1999
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CA$16.321m
  • Listing Market Cap: CA$12.306m
  • Shares outstanding: 141.92m
  • Website: https://www.medxhealth.com

Location

  • MedX Health Corp
  • 1495 Bonhill Road
  • Unit #1
  • Mississauga
  • Ontario
  • L5T 1M2
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MDXTSXV (TSX Venture Exchange)YesCommon SharesCACADFeb 2008
9MHDB (Deutsche Boerse AG)YesCommon SharesDEEURFeb 2008
MDXH.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDFeb 2008

Biography

MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in North America, Europ ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/21 00:11
End of Day Share Price2019/08/29 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.